β¨ Health-related appointments and medicine consents
4 AUGUST 2011 NEW ZEALAND GAZETTE, No. 118 3301
as pharmacist members of the Health Practitioners Disciplinary Tribunal.
These appointments are for five-year terms of office commencing on the date of this notification.
Dated at Ohope Beach this 26th day of July 2011.
HON TONY RYALL, Minister of Health.
go5337
Judith McAra-Couper
as a health practitioner member of the Midwifery Council for a three-year term of office commencing on the date of this notification; and appoint
Bronwen Golder
as a lay member of the Midwifery Council for a three-year term of office commencing on the date of this notification.
Dated at Whakatane this 28th day of July 2011.
Reappointment/appointment to the Midwifery Council
Pursuant to section 120 of the Health Practitioners Competence Assurance Act 2003, I reappoint
HON TONY RYALL, Minister of Health.
go5340
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Aspen Adrenaline
Active Ingredient: Adrenaline 1mg/10mL
Dosage Form: Solution for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Biologici Italia Laboratoires Srl, Novate Milanese, Milan, Italy
Biologici Italia Laboratoires Srl, Masate, Milan, Italy
Product: DBL Docetaxel, Concentrated Injection
Active Ingredient: Docetaxel 10mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Hospira NZ Limited
Manufacturers: Hospira Australia Pty Limited, Mulgrave, Australia
Zydus Hospira Oncology Limited (ZHOPL), Ahmedabad, India
Product: Telfast Childrenβs Elixir
Active Ingredient: Fexofenadine hydrochloride 6mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: sanofi-aventis us llc, Missouri, United States of America
Dated this 28th day of July 2011.
MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go5233
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Actilyse
Active Ingredient: Alteplase 10mg
Dosage Form: Powder for injection
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
Product: Actilyse
Active Ingredient: Alteplase 20mg
Dosage Form: Powder for injection
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
Next Page →
β¨ LLM interpretation of page content
π₯
Reappointment/appointments to the Health Practitioners Disciplinary Tribunal
(continued from previous page)
π₯ Health & Social Welfare26 July 2011
Health Practitioners, Disciplinary Tribunal, Appointments
- HON TONY RYALL, Minister of Health
π₯ Reappointment/appointment to the Midwifery Council
π₯ Health & Social Welfare28 July 2011
Midwifery Council, Appointments
- Judith McAra-Couper, Reappointed as health practitioner member
- Bronwen Golder, Appointed as lay member
- HON TONY RYALL, Minister of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare28 July 2011
Medicines, Distribution Consent
- MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare28 July 2011
Medicines, Distribution Consent
- MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
NZ Gazette 2011, No 118